Hiroyoshi Kurihara

0040053, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Real-world clinical outcomes of tirzepatide administration in older patients with type 2 diabetes, with a focus on the risk of hypoglycemia and weight loss-related parameters.

Real-world clinical outcomes of tirzepatide administration in older patients with type 2 diabetes, with a focus on the risk of hypoglycemia and weight loss-related parameters.

Journal: Endocrine journal

Published: July 15, 2026

Clinical efficacy of switching to tirzepatide in patients with type 2 diabetes and a high risk of metabolic dysfunction-associated steatotic liver disease undergoing GLP-1 receptor agonist therapy: Insights from the Hokkaido-TZP study.

Clinical efficacy of switching to tirzepatide in patients with type 2 diabetes and a high risk of metabolic dysfunction-associated steatotic liver disease undergoing GLP-1 receptor agonist therapy: Insights from the Hokkaido-TZP study.

Journal: Journal of diabetes and its complications

Published: May 28, 2026

Real-World Clinical Evidence of Tirzepatide for Metabolic Abnormalities in Subjects With Type 2 Diabetes: The Multicenter Retrospective Observational Hokkaido-TZP Study.

Real-World Clinical Evidence of Tirzepatide for Metabolic Abnormalities in Subjects With Type 2 Diabetes: The Multicenter Retrospective Observational Hokkaido-TZP Study.

Journal: Diabetes, obesity & metabolism

Published: February 05, 2026

The Effects of Oral Semaglutide on Hepatic Fibrosis in Subjects with Type 2 Diabetes in Real-World Clinical Practice: A Post Hoc Analysis of the Sapporo-Oral SEMA Study.

The Effects of Oral Semaglutide on Hepatic Fibrosis in Subjects with Type 2 Diabetes in Real-World Clinical Practice: A Post Hoc Analysis of the Sapporo-Oral SEMA Study.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 20, 2024

Real-world clinical evidence of oral semaglutide on metabolic abnormalities in subjects with type 2 diabetes: a multicenter retrospective observational study (the Sapporo-Oral SEMA study).

Real-world clinical evidence of oral semaglutide on metabolic abnormalities in subjects with type 2 diabetes: a multicenter retrospective observational study (the Sapporo-Oral SEMA study).

Journal: Endocrine journal

Published: April 24, 2024

Add-on imeglimin versus metformin dose escalation regarding glycemic control in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: study protocol for a multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study).

Add-on imeglimin versus metformin dose escalation regarding glycemic control in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: study protocol for a multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study).

Journal: BMJ open diabetes research & care

Published: June 13, 2022

EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics.

EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics.

Journal: Oncotarget

Published: September 16, 2016

MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer.

MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer.

Journal: Carcinogenesis

Published: September 10, 2016

The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway.

The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway.

Journal: Oncotarget

Published: October 28, 2015

Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.

Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.

Journal: World journal of gastroenterology

Published: June 30, 2015

Analysis of the molecular features of rectal carcinoid tumors to identify new biomarkers that predict biological malignancy.

Analysis of the molecular features of rectal carcinoid tumors to identify new biomarkers that predict biological malignancy.

Journal: Oncotarget

Published: April 01, 2015

Clinicopathological and molecular characteristics of serrated lesions in Japanese elderly patients.

Clinicopathological and molecular characteristics of serrated lesions in Japanese elderly patients.

Journal: Digestion

Published: January 31, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026